600165 宁科生物
已收盘 09-30 15:00:00
资讯
新帖
简况
宁科生物（600165）9月29日主力资金净卖出620.48万元
证券之星 · 09-29
宁科生物（600165）9月29日主力资金净卖出620.48万元
宁科生物（600165）9月28日主力资金净买入983.75万元
证券之星 · 09-28
宁科生物（600165）9月28日主力资金净买入983.75万元
宁科生物：9月23日冯战胜、金相宇增持股份合计6万股
证券之星 · 09-23
宁科生物：9月23日冯战胜、金相宇增持股份合计6万股
宁科生物：9月21日高级管理人员屈晓春增持股份合计5400股
证券之星 · 09-21
宁科生物：9月21日高级管理人员屈晓春增持股份合计5400股
每周股票复盘：宁科生物（600165）高管连续增持18.06万股
证券之星 · 09-20
每周股票复盘：宁科生物（600165）高管连续增持18.06万股
宁科生物：9月18日符杰、屈晓春、冯战胜增持股份合计18.06万股
证券之星 · 09-18
宁科生物：9月18日符杰、屈晓春、冯战胜增持股份合计18.06万股
宁科生物：9月16日董事冯战胜增持股份合计10000股
证券之星 · 09-17
宁科生物：9月16日董事冯战胜增持股份合计10000股
宁科生物：9月15日接受机构调研，中金公司、华泰证券等多家机构参与
证券之星 · 09-16
宁科生物：9月15日接受机构调研，中金公司、华泰证券等多家机构参与
宁科生物：9月14日董事冯战胜增持股份合计5000股
证券之星 · 09-14
宁科生物：9月14日董事冯战胜增持股份合计5000股
每周股票复盘：宁科生物（600165）高管9月增持92.05万股
证券之星 · 09-13
每周股票复盘：宁科生物（600165）高管9月增持92.05万股
宁科生物：9月10日至9月11日董事符杰、王炜、刘喜荣增持股份合计92.05万股
证券之星 · 09-11
宁科生物：9月10日至9月11日董事符杰、王炜、刘喜荣增持股份合计92.05万股
宁科生物（600165）披露详式权益变动报告书2026年半年度持续督导意见，9月10日股价上涨2.46%
证券之星 · 09-10
宁科生物（600165）披露详式权益变动报告书2026年半年度持续督导意见，9月10日股价上涨2.46%
宁科生物（600165）披露2026年半年度报告，8月31日股价上涨0.63%
证券之星 · 08-31
宁科生物（600165）披露2026年半年度报告，8月31日股价上涨0.63%
每周股票复盘：宁科生物（600165）ST宁科撤销风险警示复牌
证券之星 · 08-30
每周股票复盘：宁科生物（600165）ST宁科撤销风险警示复牌
宁科生物（600165）2026年中报简析：营收上升亏损收窄，盈利能力上升
证券之星 · 08-30
宁科生物（600165）2026年中报简析：营收上升亏损收窄，盈利能力上升
图解宁科生物中报：第二季度单季净利润同比增长36.26%
证券之星 · 08-29
图解宁科生物中报：第二季度单季净利润同比增长36.26%
股市必读：宁科生物（600165）8月27日收盘跌5.57%，主力净流出530.56万元
证券之星 · 08-28
股市必读：宁科生物（600165）8月27日收盘跌5.57%，主力净流出530.56万元
ST宁科最新公告：撤销其他风险警示暨停牌一天
证券之星 · 08-24
ST宁科最新公告：撤销其他风险警示暨停牌一天
每周股票复盘：ST宁科（600165）三日涨逾20%登龙虎榜
证券之星 · 08-23
每周股票复盘：ST宁科（600165）三日涨逾20%登龙虎榜
ST宁科（600165）披露涉及追偿权纠纷诉讼进展公告，8月21日股价上涨2.48%
证券之星 · 08-21
ST宁科（600165）披露涉及追偿权纠纷诉讼进展公告，8月21日股价上涨2.48%
加载更多
公司概况
公司名称：
宁夏中科生物科技股份有限公司
所属行业：
化学原料和化学制品制造业
上市日期：
1998-05-29
主营业务：
宁夏中科生物科技股份有限公司的主营业务是长链二元酸系列产品的生产及销售；煤质活性炭生产和销售。公司的主要产品是长链二元酸（生物法提取）、煤质活性炭。
发行价格：
5.00
{"stockData":{"symbol":"600165","market":"SH","secType":"STK","nameCN":"宁科生物","latestPrice":3.35,"timestamp":1790751600000,"preClose":3.25,"halted":0,"volume":18734903,"delay":0,"changeRate":0.0308,"floatShares":733000000,"shares":1616000000,"eps":-0.0321,"marketStatus":"已收盘","change":0.1,"latestTime":"09-30 15:00:00","open":3.32,"high":3.38,"low":3.24,"amount":61979800,"amplitude":0.0431,"askPrice":3.35,"askSize":642,"bidPrice":3.34,"bidSize":103,"shortable":0,"etf":0,"ttmEps":-0.0321,"tradingStatus":0,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1791423000000},"marketStatusCode":5,"adr":0,"adjPreClose":3.25,"symbolType":"stock","openAndCloseTimeList":[[1790731800000,1790739000000],[1790744400000,1790751600000]],"highLimit":3.58,"lowLimit":2.93,"ibTradeSell":true,"ibTradeBuySell":false,"totalEquity":1615883775,"isCdr":false,"pbRate":5.03,"roa":"--","roe":"0.0%","epsLYR":-0.056,"committee":-0.80813,"marketValue":5413000000,"turnoverRate":0.0256,"status":0,"nextConnectDate":"根据港交所公布的数据，今日已停止北向交易，下一个交易日为北京时间 2026-10-08。","floatMarketCap":2455000000},"requestUrl":"/m/hq/s/600165","defaultTab":"news","newsList":[{"id":"2671929188","title":"宁科生物（600165）9月29日主力资金净卖出620.48万元","url":"https://stock-news.laohu8.com/highlight/detail?id=2671929188","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2671929188?lang=zh_cn&edition=full","pubTime":"2026-09-29 15:25","pubTimestamp":1790666733,"startTime":"0","endTime":"0","summary":"证券之星消息，截至2026年9月29日收盘，宁科生物报收于3.25元，下跌3.56%，换手率2.65%，成交量19.4万手，成交额6363.21万元。9月29日的资金流向数据方面，主力资金净流出620.48万元，占总成交额9.75%，游资资金净流入793.25万元，占总成交额12.47%，散户资金净流出172.78万元，占总成交额2.72%。宁科生物主营业务：长链二元酸及煤质活性炭的生产销售业务及贸易业务。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026092900020129.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0070","BK0174","BK0229","600165","BK0042","BK0077"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2670284440","title":"宁科生物（600165）9月28日主力资金净买入983.75万元","url":"https://stock-news.laohu8.com/highlight/detail?id=2670284440","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2670284440?lang=zh_cn&edition=full","pubTime":"2026-09-28 15:21","pubTimestamp":1790580114,"startTime":"0","endTime":"0","summary":"证券之星消息，截至2026年9月28日收盘，宁科生物报收于3.37元，上涨4.98%，换手率4.14%，成交量30.34万手，成交额1.01亿元。9月28日的资金流向数据方面，主力资金净流入983.75万元，占总成交额9.71%，游资资金净流入42.76万元，占总成交额0.42%，散户资金净流出1026.52万元，占总成交额10.14%。宁科生物主营业务：长链二元酸及煤质活性炭的生产销售业务及贸易业务。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026092800014387.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0042","BK0070","BK0229","BK0077","BK0174","600165"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2669834774","title":"宁科生物：9月23日冯战胜、金相宇增持股份合计6万股","url":"https://stock-news.laohu8.com/highlight/detail?id=2669834774","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2669834774?lang=zh_cn&edition=full","pubTime":"2026-09-23 20:01","pubTimestamp":1790164906,"startTime":"0","endTime":"0","summary":"证券之星消息，根据9月23日市场公开信息、上市公司公告及交易所披露数据整理，宁科生物（600165）最新董监高及相关人员股份变动情况：2026年9月23日公司董事冯战胜、高级管理人员金相宇共增持公司股份6.0万股，占公司总股本为0.0037%。变动期间公司股价下跌3.05%，9月23日当日收盘报3.18元。宁科生物近半年内的董监高及核心技术人员增减持详情如下：宁科生物的高管列表及最新持股情况如下：该股最近90天内无机构评级。本文数据来源于上海证券交易所信息披露、宁科生物公告，仅供参考不构成投资建议。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026092300036789.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0229","600165","BK0070","BK0042","BK0174","BK0077"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2669696163","title":"宁科生物：9月21日高级管理人员屈晓春增持股份合计5400股","url":"https://stock-news.laohu8.com/highlight/detail?id=2669696163","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2669696163?lang=zh_cn&edition=full","pubTime":"2026-09-21 20:01","pubTimestamp":1789992093,"startTime":"0","endTime":"0","summary":"证券之星消息，根据9月21日市场公开信息、上市公司公告及交易所披露数据整理，宁科生物（600165）最新董监高及相关人员股份变动情况：2026年9月21日公司高级管理人员屈晓春共增持公司股份5400.0股，占公司总股本为0.0003%。变动期间公司股价上涨3.4%，9月21日当日收盘报3.35元。宁科生物近半年内的董监高及核心技术人员增减持详情如下：宁科生物的高管列表及最新持股情况如下：该股最近90天内无机构评级。本文数据来源于上海证券交易所信息披露、宁科生物公告，仅供参考不构成投资建议。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026092100028823.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0077","BK0070","BK0229","600165","BK0042","BK0174"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2668906706","title":"每周股票复盘：宁科生物（600165）高管连续增持18.06万股","url":"https://stock-news.laohu8.com/highlight/detail?id=2668906706","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2668906706?lang=zh_cn&edition=full","pubTime":"2026-09-20 01:35","pubTimestamp":1789839311,"startTime":"0","endTime":"0","summary":"截至2026年9月18日收盘，宁科生物报收于3.24元，较上周的3.21元上涨0.93%。本周，宁科生物9月17日盘中最高价报3.45元。2026年9月16日，董事冯战胜增持1.0万股，占公司总股本0.0006%。公司重视知识产权保护，将联合中国科学院微生物研究所依法维护股东权益。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026092000000314.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0229","600165","BK0070","BK0042","BK0174","BK0077"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2668940923","title":"宁科生物：9月18日符杰、屈晓春、冯战胜增持股份合计18.06万股","url":"https://stock-news.laohu8.com/highlight/detail?id=2668940923","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2668940923?lang=zh_cn&edition=full","pubTime":"2026-09-18 20:01","pubTimestamp":1789732901,"startTime":"0","endTime":"0","summary":"证券之星消息，根据9月18日市场公开信息、上市公司公告及交易所披露数据整理，宁科生物（600165）最新董监高及相关人员股份变动情况：2026年9月18日公司董事,高级管理人员符杰、高级管理人员屈晓春、董事冯战胜共增持公司股份18.06万股，占公司总股本为0.0111%。变动期间公司股价下跌4.71%，9月18日当日收盘报3.24元。宁科生物近半年内的董监高及核心技术人员增减持详情如下：宁科生物的高管列表及最新持股情况如下：该股最近90天内无机构评级。本文数据来源于上海证券交易所信息披露、宁科生物公告，仅供参考不构成投资建议。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026091800033422.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0077","BK0070","600165","BK0229","BK0042","BK0174"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2668964440","title":"宁科生物：9月16日董事冯战胜增持股份合计10000股","url":"https://stock-news.laohu8.com/highlight/detail?id=2668964440","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2668964440?lang=zh_cn&edition=full","pubTime":"2026-09-17 20:01","pubTimestamp":1789646486,"startTime":"0","endTime":"0","summary":"证券之星消息，根据9月17日市场公开信息、上市公司公告及交易所披露数据整理，宁科生物（600165）最新董监高及相关人员股份变动情况：2026年9月16日公司董事冯战胜共增持公司股份1.0万股，占公司总股本为0.0006%。变动期间公司股价上涨2.15%，9月16日当日收盘报3.32元。宁科生物近半年内的董监高及核心技术人员增减持详情如下：宁科生物的高管列表及最新持股情况如下：该股最近90天内无机构评级。本文数据来源于上海证券交易所信息披露、宁科生物公告，仅供参考不构成投资建议。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026091700032916.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0042","600165","BK0077","BK0229","BK0174","BK0070"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2667077286","title":"宁科生物：9月15日接受机构调研，中金公司、华泰证券等多家机构参与","url":"https://stock-news.laohu8.com/highlight/detail?id=2667077286","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2667077286?lang=zh_cn&edition=full","pubTime":"2026-09-16 19:01","pubTimestamp":1789556470,"startTime":"0","endTime":"0","summary":"该事项对公司业务有无影响。同时，公司一贯高度重视知识产权保护，尊重他人合法权利，始终倡导公平、有序的市场竞争秩序。公司将与中国科学院微生物研究所一道，积极、坚决维护自身及全体股东的合法权益。宁科生物主营业务：长链二元酸及煤质活性炭的生产销售业务及贸易业务。以上内容为证券之星据公开信息整理，仅供参考不构成投资建议。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026091600031710.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["LU0359201885.HKD","LU1781817850.SGD","LU2148510915.USD","LU0359202008.SGD","LU1328615791.USD","LU0359201612.USD","LU0531971595.HKD","BK1516","LU0164865239.USD","BK0183","LU1508157978.USD","BK0070","BK0028","BK0229","LU1023057109.AUD","BK0174","BK0276","SG9999002828.SGD","LU0039217434.USD","LU1808992512.USD","LU0871576103.HKD","BK0077","BK0012","BK1147","BK1564","BK1501","LU1064131003.USD","601995","03908","LU1580142542.USD","601688","LU1064130708.USD","LU1934453819.USD","600165","LU1979443071.USD","BK0042","LU2663582299.SGD","BK0188"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2667665560","title":"宁科生物：9月14日董事冯战胜增持股份合计5000股","url":"https://stock-news.laohu8.com/highlight/detail?id=2667665560","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2667665560?lang=zh_cn&edition=full","pubTime":"2026-09-14 20:01","pubTimestamp":1789387285,"startTime":"0","endTime":"0","summary":"证券之星消息，根据9月14日市场公开信息、上市公司公告及交易所披露数据整理，宁科生物（600165）最新董监高及相关人员股份变动情况：2026年9月14日公司董事冯战胜共增持公司股份5000.0股，占公司总股本为0.0003%。变动期间公司股价上涨1.87%，9月14日当日收盘报3.27元。宁科生物近半年内的董监高及核心技术人员增减持详情如下：宁科生物的高管列表及最新持股情况如下：该股最近90天内无机构评级。本文数据来源于上海证券交易所信息披露、宁科生物公告，仅供参考不构成投资建议。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026091400029517.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0042","BK0077","BK0229","BK0070","600165","BK0174"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2667500639","title":"每周股票复盘：宁科生物（600165）高管9月增持92.05万股","url":"https://stock-news.laohu8.com/highlight/detail?id=2667500639","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2667500639?lang=zh_cn&edition=full","pubTime":"2026-09-13 03:21","pubTimestamp":1789240871,"startTime":"0","endTime":"0","summary":"截至2026年9月11日收盘，宁科生物报收于3.21元，较上周的3.14元上涨2.23%。本周，宁科生物9月10日盘中最高价报3.39元。本周关注点股本股东变化：宁科生物高管符杰、王炜、刘喜荣9月10日至11日合计增持92.05万股。2026年9月8日，董事兼高管王炜增持公司股份2.0万股，占总股本0.0012%。本次权益变动后，湖南新合新持有公司357,142,857股，占总股本22.10%，成为控股股东，公司实际控制人由虞建明变更为刘喜荣。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026091300001020.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0042","BK0077","BK0229","BK0070","600165","BK0174"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2666521082","title":"宁科生物：9月10日至9月11日董事符杰、王炜、刘喜荣增持股份合计92.05万股","url":"https://stock-news.laohu8.com/highlight/detail?id=2666521082","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2666521082?lang=zh_cn&edition=full","pubTime":"2026-09-11 20:01","pubTimestamp":1789128102,"startTime":"0","endTime":"0","summary":"证券之星消息，根据9月11日市场公开信息、上市公司公告及交易所披露数据整理，宁科生物（600165）最新董监高及相关人员股份变动情况：2026年9月10日至2026年9月11日公司董事,高级管理人员符杰、董事,高级管理人员王炜、董事刘喜荣共增持公司股份92.05万股，占公司总股本为0.057%。变动期间公司股价下跌1.23%，9月11日当日收盘报3.21元。宁科生物近半年内的董监高及核心技术人员增减持详情如下：宁科生物的高管列表及最新持股情况如下：该股最近90天内无机构评级。本文数据来源于上海证券交易所信息披露、宁科生物公告，仅供参考不构成投资建议。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026091100045259.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["600165","BK0070","BK0042","BK0077","BK0229","BK0174"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2666591477","title":"宁科生物（600165）披露详式权益变动报告书2026年半年度持续督导意见，9月10日股价上涨2.46%","url":"https://stock-news.laohu8.com/highlight/detail?id=2666591477","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2666591477?lang=zh_cn&edition=full","pubTime":"2026-09-10 22:24","pubTimestamp":1789050258,"startTime":"0","endTime":"0","summary":"截至2026年9月10日收盘，宁科生物报收于3.33元，较前一交易日上涨2.46%，最新总市值为53.81亿元。该股当日开盘3.27元，最高3.39元，最低3.17元，成交额达6599.96万元，换手率为2.73%。公告显示，国泰海通证券作为财务顾问，对宁夏中科生物科技股份有限公司权益变动事项出具2026年半年度持续督导意见。本次权益变动后，湖南新合新持有公司357,142,857股，占总股本22.10%，成为控股股东，实际控制人由虞建明变更为刘喜荣。资本公积转增股份已完成过户，投资款项已到位。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026091000042145.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0042","600165","BK0077","BK0070","BK0174","BK0229"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2663074862","title":"宁科生物（600165）披露2026年半年度报告，8月31日股价上涨0.63%","url":"https://stock-news.laohu8.com/highlight/detail?id=2663074862","media":"证券之星","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2663074862?lang=zh_cn&edition=full","pubTime":"2026-08-31 18:07","pubTimestamp":1788170851,"startTime":"0","endTime":"0","summary":"截至2026年8月31日收盘，宁科生物报收于3.18元，较前一交易日上涨0.63%，最新总市值为51.39亿元。该股当日开盘3.1元，最高3.23元，最低3.09元，成交额达6093.97万元，换手率为2.63%。近日，公司披露《宁夏中科生物科技股份有限公司2026年半年度报告》。公告显示，本报告期末总资产为2,341,320,637.37元，上年度末为2,318,555,923.88元，本报告期末比年度末增减0.98%。本报告期营业收入为274,368,872.09元，上年同期为215,589,251.30元，同比增长27.26%。报告期内公司未实施利润分配预案、资本公积金转增股本预案。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026083100026028.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0174","BK0070","600165","BK0042","BK0229","BK0077"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2663404326","title":"每周股票复盘：宁科生物（600165）ST宁科撤销风险警示复牌","url":"https://stock-news.laohu8.com/highlight/detail?id=2663404326","media":"证券之星","labels":["corporation"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2663404326?lang=zh_cn&edition=full","pubTime":"2026-08-30 08:20","pubTimestamp":1788049225,"startTime":"0","endTime":"0","summary":"截至2026年8月28日收盘，宁科生物报收于3.16元，较上周的3.31元下跌4.53%。本周，宁科生物8月26日盘中最高价报3.6元。本周关注点来自公司公告汇总：ST宁科于2026年8月26日起撤销其他风险警示，证券简称变更为“宁科生物”。公司于2026年8月15日向上交所申请撤销其他风险警示，获上交所于8月24日批准。宁科生物2026年半年度报告摘要公司代码600165，简称宁科生物。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026083000004243.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0042","600165","BK0077","BK0070","BK0174","BK0229"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2663048626","title":"宁科生物（600165）2026年中报简析：营收上升亏损收窄，盈利能力上升","url":"https://stock-news.laohu8.com/highlight/detail?id=2663048626","media":"证券之星","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2663048626?lang=zh_cn&edition=full","pubTime":"2026-08-30 06:03","pubTimestamp":1788040984,"startTime":"0","endTime":"0","summary":"据证券之星公开数据整理，近期宁科生物发布2026年中报。截至本报告期末，公司营业总收入2.74亿元，同比上升27.26%，归母净利润-1.32亿元，同比上升22.53%。本报告期宁科生物盈利能力上升，毛利率同比增幅76.25%，净利率同比增幅45.12%。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026083000001855.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["600165"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2663678018","title":"图解宁科生物中报：第二季度单季净利润同比增长36.26%","url":"https://stock-news.laohu8.com/highlight/detail?id=2663678018","media":"证券之星","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2663678018?lang=zh_cn&edition=full","pubTime":"2026-08-29 02:05","pubTimestamp":1787940322,"startTime":"0","endTime":"0","summary":"证券之星消息，宁科生物2026年中报显示，上半年度公司主营收入2.74亿元，同比上升27.26%；归母净利润-1.32亿元，同比上升22.53%；扣非净利润-1.33亿元，同比上升0.55%；其中2026年第二季度，公司单季度主营收入1.57亿元，同比上升28.7%；单季度归母净利润-6815.33万元，同比上升36.26%；单季度扣非净利润-6835.88万元，同比上升11.48%；负债率48.59%，财务费用1424.13万元，毛利率-6.02%。财报数据概要请见下图:本文数据来源于宁科生物2026年中报，仅供参考不构成投资建议。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026082900005883.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["600165"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662331690","title":"股市必读：宁科生物（600165）8月27日收盘跌5.57%，主力净流出530.56万元","url":"https://stock-news.laohu8.com/highlight/detail?id=2662331690","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2662331690?lang=zh_cn&edition=full","pubTime":"2026-08-28 04:34","pubTimestamp":1787862852,"startTime":"0","endTime":"0","summary":"截至2026年8月27日收盘，宁科生物报收于3.22元，下跌5.57%，换手率5.15%，成交量37.76万手，成交额1.22亿元。交易信息汇总：8月27日主力资金净流出530.56万元，占总成交额4.34%；散户资金净流入473.77万元，占总成交额3.87%。交易信息汇总股价提醒8月27日宁科生物收盘报3.22元，跌5.57%，当日成交1.22亿元。前10个交易日主力资金累计净流出1939.65万元，股价累计下跌5.57%；融资余额累计减少669.49万元，融券余量累计减少4.01万股。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026082800009335.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0077","BK0070","BK0229","600165","BK0042","BK0174"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2661622006","title":"ST宁科最新公告：撤销其他风险警示暨停牌一天","url":"https://stock-news.laohu8.com/highlight/detail?id=2661622006","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2661622006?lang=zh_cn&edition=full","pubTime":"2026-08-24 18:20","pubTimestamp":1787566824,"startTime":"0","endTime":"0","summary":"宁科生物(600165.SH)公告称，公司股票将于2026年8月25日开市起停牌1天，并于8月26日复牌。撤销其他风险警示后，A股证券简称由“ST宁科”变更为“宁科生物”，证券代码不变，股票转出风险警示板交易，日涨跌幅限制为10%。以上内容为证券之星据公开信息整理，仅供参考不构成投资建议。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026082400026350.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["600165","BK0229","BK0077","BK0174","BK0070","BK0042"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2661117552","title":"每周股票复盘：ST宁科（600165）三日涨逾20%登龙虎榜","url":"https://stock-news.laohu8.com/highlight/detail?id=2661117552","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2661117552?lang=zh_cn&edition=full","pubTime":"2026-08-23 02:40","pubTimestamp":1787424018,"startTime":"0","endTime":"0","summary":"截至2026年8月21日收盘，ST宁科报收于3.31元，较上周的2.43元上涨36.21%。本周，ST宁科8月20日盘中最高价报3.36元。本周关注点来自交易信息汇总：ST宁科因三日收盘价涨幅偏离值累计达20%登上龙虎榜。来自公司公告汇总：ST宁科收到法院终审判决，无需承担华辉环保追偿权纠纷连带责任。ST宁科股票于2026年8月17日至19日连续三个交易日收盘价涨幅偏离值累计超20%，构成异常波动。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026082300000500.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0077","BK0042","600165","BK0070","BK0229","BK0174"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2661613342","title":"ST宁科（600165）披露涉及追偿权纠纷诉讼进展公告，8月21日股价上涨2.48%","url":"https://stock-news.laohu8.com/highlight/detail?id=2661613342","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2661613342?lang=zh_cn&edition=full","pubTime":"2026-08-21 17:49","pubTimestamp":1787305759,"startTime":"0","endTime":"0","summary":"截至2026年8月21日收盘，ST宁科报收于3.31元，较前一交易日上涨2.48%，最新总市值为53.49亿元。该股当日开盘3.2元，最高3.34元，最低3.11元，成交额达9444.89万元，换手率为3.96%。公司于近日披露《关于涉及追偿权纠纷诉讼的进展公告》。公告显示，宁夏中科生物科技股份有限公司收到宁夏回族自治区石嘴山市中级人民法院终审判决书宁02民终649号，就华辉环保提起的追偿权纠纷案，法院驳回上诉，维持原判。公司将持续关注诉讼进展并履行信息披露义务。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026082100033005.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0077","BK0229","600165","BK0174","BK0070","BK0042"],"isVideo":false,"video":null,"gpt_icon":0}],"profile":{"ret":0,"serverTime":1791191935784,"stockEarnings":[{"period":"1week","weight":0.0535},{"period":"1month","weight":0.0535},{"period":"3month","weight":0.2182},{"period":"6month","weight":0.0213},{"period":"1year","weight":0.2421},{"period":"ytd","weight":-0.1928}],"compareEarnings":[{"period":"1week","weight":-0.024},{"period":"1month","weight":-0.0362},{"period":"3month","weight":-0.0463},{"period":"6month","weight":-0.0098},{"period":"1year","weight":-0.0105},{"period":"ytd","weight":-0.0319}],"compareStock":{"symbol":"000001.SH","name":"上证指数"},"companyName":"宁夏中科生物科技股份有限公司","boardCode":"AI0026","boardName":"化学原料和化学制品制造业","stockholders":"16702人(较上一季度减少1.34%)","perCapita":"43881股","listingDate":"1998-05-29","address":"宁夏回族自治区石嘴山市惠农区河滨街","registeredCapital":"161588万元","survey":" 宁夏中科生物科技股份有限公司的主营业务是长链二元酸系列产品的生产及销售；煤质活性炭生产和销售。公司的主要产品是长链二元酸（生物法提取）、煤质活性炭。","listedPrice":5},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"isLaohu8Offline":false,"tenantId":"TBCN","deviceId":"web-server-community-laohu8-v3","version":"4.50.1","shortVersion":"4.50.1","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"宁科生物(600165)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供宁科生物(600165)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"宁科生物,600165,宁科生物股票,宁科生物股票老虎,宁科生物股票老虎国际,宁科生物行情,宁科生物股票行情,宁科生物股价,宁科生物股市,宁科生物股票价格,宁科生物股票交易,宁科生物股票购买,宁科生物股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"宁科生物(600165)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供宁科生物(600165)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}